|
UBE2G1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.274600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.805200E-01 |
| Normal-vs-Stage2 |
8.089600E-01 |
| Normal-vs-Stage3 |
2.141800E-01 |
| Normal-vs-Stage4 |
8.442400E-02 |
| Stage1-vs-Stage2 |
2.710600E-01 |
| Stage1-vs-Stage3 |
5.321600E-01 |
| Stage1-vs-Stage4 |
2.453600E-01 |
| Stage2-vs-Stage3 |
1.770770E-01 |
| Stage2-vs-Stage4 |
9.578000E-02 |
| Stage3-vs-Stage4 |
5.420600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.773000E-01 |
| Normal-vs-AfricanAmerican |
8.042600E-01 |
| Normal-vs-Asian |
1.724770E-01 |
| Caucasian-vs-AfricanAmerican |
3.116200E-01 |
| Caucasian-vs-Asian |
5.973000E-01 |
| AfricanAmerican-vs-Asian |
2.119800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.103000E-01 |
| Normal-vs-Female |
3.216000E-01 |
| Male-vs-Female |
8.605200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.764000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.001800E-02 |
| Normal-vs-Age(61-80Yrs) |
9.319000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.892200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.602810E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.758800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.414800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.094300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.921600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.401400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.479200E-01 |
| Classical-VS-Follicular |
8.387600E-01 |
| Classical-VS-Other |
1.200810E-01 |
| Classical-VS-Normal |
4.606000E-01 |
| Tall-VS-Follicular |
8.675200E-01 |
| Tall-VS-Other |
1.739820E-01 |
| Tall-VS-Normal |
6.554200E-01 |
| Follicular-VS-Other |
2.377000E-01 |
| Follicular-VS-Normal |
4.409200E-01 |
| Other-VS-Normal |
5.171900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.081400E-01 |
| Normal-vs-N1 |
2.466200E-02 |
| N0-vs-N1 |
1.241570E-01 |
|
|
